The latest price target for Amdocs (NASDAQ:DOX) was reported by Citigroup on May 9, 2024. The analyst firm set a price target for $100.00 expecting DOX to rise to within 12 months (a possible 14.56% upside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Amdocs (NASDAQ:DOX) was provided by Citigroup, and Amdocs maintained their buy rating.

The last upgrade for Amdocs Ltd happened on May 16, 2023 when Barclays raised their price target to $115. Barclays previously had an equal-weight for Amdocs Ltd.

The last downgrade for Amdocs Ltd happened on December 14, 2021 when JP Morgan changed their price target from $91 to $86 for Amdocs Ltd.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amdocs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amdocs was filed on May 9, 2024 so you should expect the next rating to be made available sometime around May 9, 2025.

While ratings are subjective and will change, the latest Amdocs (DOX) rating was a maintained with a price target of $105.00 to $100.00. The current price Amdocs (DOX) is trading at is $87.29, which is out of the analyst’s predicted range.